IVIg vs SCIg
Proportion of participants with side effects attributable to treatment · people with multifocal motor neuropathy
It is very uncertain whether IVIg changes proportion of participants with side effects attributable to treatment compared with SCIg (very low certainty).
1 finding from 1 review
- RR 0.5 [0.18, 1.4]9 participantsVery low